(Q40150475)

17 September 2017

1 reference

title

The biologic background to some therapeutic uses of aspirin (English)

1 reference

17 September 2017

1 reference

G. V. Born

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6344623

3 October 2023

P. Görög

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6344623

3 October 2023

N. A. Begent

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6344623

3 October 2023

language of work or name

English

0 references

publication date

1 June 1983

1 reference

17 September 2017

14 June 1983

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6344623

full work available at URL

3 October 2023

https://api.elsevier.com/content/article/PII:0002934383905223?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

https://api.elsevier.com/content/article/PII:0002934383905223?httpAccept=text/plain

3 October 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

American Journal of Medicine

3 October 2023

published in

1 reference

17 September 2017

volume

74

1 reference

17 September 2017

issue

6A

1 reference

17 September 2017

page(s)

2-9

1 reference

Pharmakologisches über Aspirin (Acetylsalicylsäure)

17 September 2017

cites work

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

The fate of acetylsalicylic acid

3 October 2023

5

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

3 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

Prostaglandins: Their Disappearance from and Release into the Circulation

3 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

The release of prostaglandins from lung and other tissues

3 October 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

Prostaglandins, Aspirin-like Drugs and Analgesia

3 October 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

Aspirin selectively inhibits prostaglandin production in human platelets

3 October 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs

3 October 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

Acetylation of Sickle Cell Hemoglobin by Aspirin

3 October 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

The acetylation of hemoglobin by aspirin. In vitro and in vivo

3 October 2023

18

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

Acetylation of erythrocytic membrane peptides by aspirin

3 October 2023

19

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

Secondary prevention after myocardial infarction: A review of long-term trials

3 October 2023

20

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

Controlled trial of aspirin in cerebral ischemia

3 October 2023

21

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

Activation time of blood platelets

3 October 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

Aggregation of platelets by collagen

3 October 2023

30

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

Factors affecting hemostatic plug formation in an extracorporeal model

3 October 2023

31

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

Regional administration of drugs to control thrombosis in artificial organs

3 October 2023

32

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

Effect of ADP-utilizing enzymes on the arterial bleeding time in rats and rabbits

3 October 2023

33

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

Endogenous agents in platelet thrombosis

3 October 2023

34

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

Aggregation of platelets in damaged vessels

3 October 2023

35

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

Fluid-mechanical and biochemical interactions in haemostasis

3 October 2023

36

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

STUDIES IN EXPERIMENTAL EXTRACORPOREAL THROMBOSIS : I. A METHOD FOR THE DIRECT OBSERVATION OF EXTRACORPOREAL THROMBUS FORMATION.

3 October 2023

37

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

Factors influencing thrombus formation in vivo

3 October 2023

38

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

Localization of atheroma: a theory based on boundary layer separation

3 October 2023

39

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

Platelet interaction with subendothelium in a perfusion system: Physical role of red blood cells

3 October 2023

41

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

The flow of model particles and blood cells and its relation to thrombogenesis

3 October 2023

42

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

Growth Rate in vivo of Platelet Thrombi, produced by Iontophoresis of ADP, as a Function of Mean Blood Flow Velocity

3 October 2023

43

1 reference

https://api.crossref.org/works/10.1016/0002-9343(83)90522-3

3 October 2023

Identifiers

1 reference

17 September 2017

1 reference